The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma


Erdem S., Yegen G., Telci D., Yildiz İ. , Tefik T., Issever H., et al.

WORLD JOURNAL OF UROLOGY, cilt.33, ss.1553-1560, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 33 Konu: 10
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1007/s00345-014-1462-7
  • Dergi Adı: WORLD JOURNAL OF UROLOGY
  • Sayfa Sayısı: ss.1553-1560

Özet

The aim of this study was to investigate the role of transglutaminase 2(TG2) in renal cell carcinoma (RCC) by comparing the immunohistochemistry staining of primary and metastatic tumor tissues.